Skip to main content
. 2022 Nov 24;12:1014888. doi: 10.3389/fonc.2022.1014888

Table 1.

Prognostic value of 4 target genes expression for BCR free survival by Cox proportional hazards model.

Variable BCR free survival
HR (95%CI) P
Univariate analysis
Age (≤60 or >60) 1.10 (0.64-1.90) 0.720
Gleason score (≤8 or >8) 2.70 (1.50-4.60) <0.001***
Tumor Stage (T1-T2 or T3-T4) 5.20 (2.00-13.00) <0.001***
Lymph node stage (N0 or N1) 2.00 (1.10-3.50) 0.025*
Distant metastasis (M0 or M1) 0.00 (0.00-2.00) 1.000
PSA (<2 or ≥2) 9.00 (5.00-16.00) <0.001***
Risk score (Low risk or High risk) 2.30 (1.30-4.20) 0.004**
Multivariate analysis
Gleason score (≤8 or >8) 1.19 (0.66-2.13) 0.568
Tumor Stage (T1-T2 or T3-T4) 3.52 (1.31-9.46) 0.013*
Lymph node stage (N0 or N1) 1.25 (0.68-2.29) 0.474
PSA (<2 or ≥2) 7.19 (3.96-13.04) <0.001***
Risk score (Low risk or High risk) 1.63 (0.90-2.92) 0.105

*means the difference is significant at the 0.05 level ,** means the difference is significant at the 0.01 level , *** means the difference is significant at the 0.01 level.